Shareholders meeting

Date: September 07, 2026 The Listing Department National Stock Exchange of lndia Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400051, Maharashtra. SYMBOL: QMSMEDI Sub: Notice of the 09th Annual General Meeting (‘AGM’) of the Company for FY 2025-26 Dear Sir/Ma’am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the Notice and the Explanatory Statement of the 09th AGM of the Company scheduled to be held on Wednesday, September 30, 2026 at 02:30 p.m. (IST) through Video Conferencing facility / Other Audio-Visual Means. The said Notice forms part of the Annual Report 2025-26 The Annual Report 2025-26 will be available on the website of the Company at https://qmsmas.com/. This is for your information and records. Thanking you, Yours sincerely, For QMS MEDICAL ALLIED SERVICES LIMITED Toral Jailesh Bhadra (Membership Number: A56927) (Company Secretary and Compliance Officer) Place: Mumbai Encl: As above CIN: L33309MH2017PLC299748; Email ID: mm@qmsmas.com NOTICE OF 9TH ANNUAL GENERAL MEETING Notice is hereby given that the Ninth Annual General Meeting of the Members of QMS MEDICAL ALLIED SERVICES LIMITED will be held on Wednesday, September 30, 2026 at 02:30 P.M. through Video Conferencing or Other Audio Visual means, to transact the following business. The venue of the meeting shall be deemed to be the Registered Office of the Company at A1 A2/B1 B2, Navkala Bharti Bldg Plot No 16 Prabhat Colony Opp Near Santacruz Bus Depot Santacruz East, Mumbai 400055, Maharashtra, India to transact the following business: Ordinary Business 1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon. 2. To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon. 3. To appoint a Director in place of Mr. Mahesh Pahalraj Makhija (DIN: 02700606) who retires by rotation and, being eligible, offers himself for re-appointment as Director of the Company. Accordingly, to consider and it thought fit, pass the following resolution as ordinary resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, the approval of the member of the company be, and is hereby accorded for re-appointment of Mr. Mahesh Pahalraj Makhija (DIN: 02700606), Managing Director, to extent that he is required to retire by rotation.” 4. To declare a final dividend of Re. 0.50 (i.e. 5%) per equity share of face value Rs. 10/- each for the financial year ended March 31, 2026. Special Business 5. Regularisation of Additional Director. Mr. Pranav Manhar Badheka (DIN: 06460764) by appointing him as Independent Director of the Company: To consider and if thought fit, to pass with or without modification(s), the following resolution as a Special Resolution: RESOLVED THAT Mr. Pranav Manhar Badheka (DIN: 06460764) who was appointed by the Board of Directors as an Additional Director (Independent, Non-Executive) of the Company with effect from September 03, 2026 and who holds office up to the date of this Annual General Meeting of the Company in terms of Section 161(1) of the Companies Act, 2013 (“Act”) and Articles of Association of the Company but who is eligible for appointment, in respect of whom the Company has received a notice in writing from a member under Section 160(1) of the Act proposing his candidature for the office of Director of the Company, be and is hereby appointed as Director (Independent, Non-Executive) of the Company. RESOLVED FURTHER THAT pursuant to the provisions of Sections 149, 152 and other applicable provisions, if any, of the Act, the Companies (Appointment and Qualifications of Directors) Rules, 2014, read with Schedule IV to the Act and Regulation 17 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), as amended from time to time, the appointment of Mr. Pranav Manhar Badheka who meets the criteria for independence as provided in Section 149(6) of the Act along with the rules framed thereunder and Regulation 16(1)(b) of SEBI Listing Regulations and who has submitted a declaration to that effect, and who is eligible for appointment as an Independent Director of the Company, be and is hereby appointed as an Independent Director of the Company, not liable to retire by rotation, for a term of five years commencing September 03, 2026 to September 02, 2031 be and is hereby approved. RESOLVED FURTHER THAT Board of Directors of the Company be and are hereby severally authorized to do and perform all such acts, deeds, matters and things, as may be considered necessary, desirable or expedient to give effect to this resolution.” 6. Approval for Material Related Party Transactions with Subsidiary Company Saarathi Healthcare Private Limited: To consider and if thought fit, to pass with or without modification(s), the following resolution as an Ordinary Resolution: RESOLVED THAT pursuant to Regulations 2(1)(zc) and 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Section 188 of the Companies Act, 2013 read with the rules framed thereunder (including any statutory modifications or re-enactments thereof), and the Company’s Policy on Related Party Transactions, and subject to the recommendation of the Audit Committee and approval of the Board of Directors, consent of the Members of the Company be and is hereby accorded to the Board of Directors (hereinafter referred to as "the Board", which term shall include any Committee thereof or any Director/Officer authorised by the Board) to enter into and/or continue entering into contract(s), arrangement(s), or transaction(s) with Saarathi Healthcare Private Limited, a subsidiary and related party of the Company, as detailed in the Explanatory Statement annexed hereto, for an aggregate value not exceeding ₹20 Crore (Rupees Twenty Crore Only), provided that all such transactions are undertaken in the ordinary course of business and on an arm's length basis, and that the Board is hereby fully authorised to execute all necessary agreements, delegate powers, make regulatory filings, and do all such acts, deeds, and things as may be necessary to give full effect to this resolution. RESOLVED FURTHER THAT the Board be and is hereby authorised to do and perform all such acts, deeds, matters and things as may be necessary, including finalising the terms and conditions, methods and modes in respect thereof, finalising and executing all necessary agreements, contracts, deeds, writings and other documents, filing applications and making representations before the appropriate authorities, and to take all such steps as may be necessary, desirable or expedient to give effect to this Resolution and to settle any question, difficulty or doubt that may arise in this regard or incidental thereto, without requiring any further approval of the Members of the Company. RESOLVED FURTHER THAT the Board be and is hereby authorised to delegate all or any of the powers conferred by this Resolution to any Committee of the Board or to any Director(s), Key Managerial Personnel, Officer(s) or Authorised Representative(s) of the Company, as may be deemed necessary or expedient for the purpose of giving effect to this Resolution.” FOR QMS MEDICAL ALLIED SERVICES LIMITED SD/- SD/- Mahesh Makhija D E E N A NATH PATHAK DIN: 02700606 DIN: 02104727 Managing Director Non-Executive Director Add: A1 A2/B1 B2, Navkala Bharti Bldg Plot No16 Prabhat Colony Opp Near Santacruz Bus Depot, Santacruz East, Mumbai City, Maharashtra, India, 400055 DATE: September 03, 2026 PLA [Showing first 8,000 characters — download PDF for full document]